Prevention & lipidsResearch article
Association of respiratory infections and the impact of vaccinations on cardiovascular diseases
- Narrative review
Study context
- Population
- Elderly and patients with CV risk factors
- Comparison
- Influenza and pneumococcal vaccination and CVD
Main finding
As reported in the abstract
CV outcomes with vaccination
- Influenza vaccination: potential benefit for primary and secondary prevention of CVD across all ages
- Pneumococcal vaccination associated with reduced risk of CV events in individuals aged ≥65 years
- Vaccination rates remain sub-optimal in this population
Original publication
Association of respiratory infections and the impact of vaccinations on cardiovascular diseases. Eur J Prev Cardiol. Published 11 January 2024. doi:10.1093/eurjpc/zwae016
Summarised from the published abstract; every number is checked against it